You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for New Drug Application (NDA): 021673

✉ Email this page to a colleague

« Back to Dashboard

NDA 021673 describes CLOLAR, which is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. Additional details are available on the CLOLAR profile page.

The generic ingredient in CLOLAR is clofarabine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clofarabine profile page.

Summary for 021673

Tradename:	CLOLAR
Applicant:	Genzyme
Ingredient:	clofarabine
Patents:	0

Pharmacology for NDA: 021673

Mechanism of Action	Nucleic Acid Synthesis Inhibitors

Suppliers and Packaging for NDA: 021673

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CLOLAR	clofarabine	SOLUTION;INTRAVENOUS	021673	NDA	Sanofi-Aventis U.S. LLC	0024-5860	0024-5860-01	1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) / 20 mL in 1 VIAL, SINGLE-USE
CLOLAR	clofarabine	SOLUTION;INTRAVENOUS	021673	NDA AUTHORIZED GENERIC	Winthrop U.S, a business of sanofi-aventis U.S. LLC	0955-1746	0955-1746-01	1 VIAL, SINGLE-USE in 1 BOX (0955-1746-01) / 20 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	20MG/20ML (1MG/ML)
Approval Date:	Dec 28, 2004	TE:	AP	RLD:	Yes

Expired US Patents for NDA 021673

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Genzyme	CLOLAR	clofarabine	SOLUTION;INTRAVENOUS	021673-001	Dec 28, 2004	⤷ Try a Trial	⤷ Try a Trial
Genzyme	CLOLAR	clofarabine	SOLUTION;INTRAVENOUS	021673-001	Dec 28, 2004	⤷ Try a Trial	⤷ Try a Trial
Genzyme	CLOLAR	clofarabine	SOLUTION;INTRAVENOUS	021673-001	Dec 28, 2004	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.